Shorts are trapped, page-70

So much to disliked about this company under this guys weak, lazy and self serving management but knowing just how great the drug works and the fact ANYONE with lightly pigmented skin would benefit significantly from its usage, I still have hopes of incredible success , just not with this guy with his feeble business model.

Im certain NSV will be approved (at some stage) but the issue for me doesn’t concern approval, it’s the likelihood that NSV (under Wolgen management) will turn out to be a piss poor half baked effort (just like EPP) where biased foolish regulators dismiss and completely ignore the evidence and patients struggle to gain access to scenesse with it still being treated like poison and locked away in “special centres” like no other drug on the planet, because imagine the damage to society if ever a super safe drug like scenesse , that protected skin from sunlight overexposure by stimulating endogenous natural photo protective eumelanin pigment would do to a skin cancer riddled upside down clown show world , where healthy disease destroying sunlight is made out to be the enemy and toxic endocrine disrupting suncream use is promoted for EVERY day usage even whilst indoors! …….. Wolgens plan is to do as little as possible and say nothing (expend minimal energy!) whilst living like a king taking home millions buying no CUV but collecting millions of free CUV .

$50 at AGM time won’t change my outlook on this guy unfortunately.